We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

17 hedge funds and large institutions have $2.95M invested in Biocept, Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

131% more call options, than puts

Call options by funds: $120K | Put options by funds: $52K

13% more funds holding

Funds holding: 15 → 17 (+2)

3% more capital invested

Capital invested by funds: $2.87M → $2.95M (+$80K)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
1
Calls
$120K
Puts
$52K
Net Calls
+$68K
Net Calls Change
-$49K

Top Buyers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
+$355K
2
VF
Virtu Financial
New York
+$47.4K
3
Millennium Management
Millennium Management
New York
+$35.5K
4
CA
Cetera Advisors
Colorado
+$11.8K
5
TSS
Two Sigma Securities
New York
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
IP
Intellectus Partners
California
-$11.8K
2
Deutsche Bank
Deutsche Bank
Germany
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$950K +$11.8K +1 +1%
BlackRock
2
BlackRock
New York
$940K – – –
Creative Planning
3
Creative Planning
Kansas
$628K +$355K +30 +111%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$82K – – –
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$52K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$44K – – –
VF
7
Virtu Financial
New York
$39K +$47.4K +4 New
GBA
8
Garrison Bradford & Associates
New York
$31K – – –
RJA
9
Raymond James & Associates
Florida
$31K – – –
US Bancorp
10
US Bancorp
Minnesota
$30K – – –
Millennium Management
11
Millennium Management
New York
$28K +$35.5K +3 New
Northern Trust
12
Northern Trust
Illinois
$20K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$18K – – –
TSS
14
Two Sigma Securities
New York
$15K +$11.8K +1 New
Morgan Stanley
15
Morgan Stanley
New York
$12K – – –
State Street
16
State Street
Massachusetts
$12K – – –
CA
17
Cetera Advisors
Colorado
$12K +$11.8K +1 New
IP
18
Intellectus Partners
California
$3K -$11.8K -1 Closed
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$1K – – –
Deutsche Bank
20
Deutsche Bank
Germany
– -$4K – –

BIOC Hedge Fund Activity: Q3 2017 in Review

17 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2017, worth a combined $2.95M — up 2.8% from $2.87M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOC positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Creative Planning, adding an estimated $355K. The largest seller was Intellectus Partners, exiting entirely with an estimated $11.8K sold.

  • 17 institutional investors held Biocept, Inc. (BIOC) as of Q3 2017, up from 15 in Q2 2017.
  • Funds reported $2.95M of Biocept, Inc. stock for Q3 2017, up 2.8% quarter-over-quarter.
  • 4 funds opened new Biocept, Inc. positions in Q3 2017 and 1 closed out, a net change of +3 holders.
  • The largest Biocept, Inc. buyer in Q3 2017 was Creative Planning, an estimated $355K added.
  • The largest Biocept, Inc. seller in Q3 2017 was Intellectus Partners, an estimated $11.8K sold.

Based on aggregated 13F filings for Q3 2017.